Related references
Note: Only part of the references are listed.Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition
Mathias Cavaille et al.
GENES CHROMOSOMES & CANCER (2021)
Severe telomere shortening in Fanconi anemia complementation group L
Anjali Shah et al.
MOLECULAR BIOLOGY REPORTS (2021)
Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer
Jesus Fuentes-Antras et al.
CANCERS (2021)
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Comparison of BRCA versus non-BRCA germline mutations and is associated somatic mutation profiles in patients with unselected breast cancer
Bo Chen et al.
AGING-US (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases
Gisella Figlioli et al.
CANCERS (2020)
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
Sonali Joshi et al.
Oncotarget (2020)
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
Haohui Duan et al.
JOURNAL OF CELL BIOLOGY (2020)
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
Solene De Talhouet et al.
SCIENTIFIC REPORTS (2020)
The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma A meta-analysis
Shu Li et al.
MEDICINE (2020)
Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients
Jesus del Valle et al.
CANCERS (2020)
Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome
Concetta Santonocito et al.
CANCERS (2020)
DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex
Renjing Wang et al.
NATURE (2020)
Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
Can-Bin Fang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
MDA-MB-157 Cell Line Presents High Levels of MAD2L2 and Dysregulated Mitosis
Nomi Pernicone et al.
ANTICANCER RESEARCH (2020)
Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis
Khadiga Abdulrashid et al.
BMC CANCER (2019)
Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer
Liang Feng et al.
ONCOLOGY LETTERS (2019)
Deleterious Mutations in DNA Repair Gene FANCC Exist in BRCA1/2-Negative Chinese Familial Breast and/or Ovarian Cancer Patients
Zhi-Wen Pan et al.
FRONTIERS IN ONCOLOGY (2019)
Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Rajendra Bahadur Shahi et al.
BMC CANCER (2019)
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients
Anna Nurmi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
FANCM, RAD1, CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer
Jaime L. Lopes et al.
CANCER GENETICS (2019)
Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms
Le Wang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Phosphorylation of FANCD2 Inhibits the FANCD2/FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage
David Lopez-Martinez et al.
CELL REPORTS (2019)
Inherited variants in XRCC2 and the risk of breast cancer
Wojciech Kluzniak et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
Shu Lin et al.
CELL DEATH & DISEASE (2019)
Structure of the Fanconi anaemia monoubiquitin ligase complex
Shabih Shakeel et al.
NATURE (2019)
Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
Rick A. C. M. Boonen et al.
NATURE COMMUNICATIONS (2019)
Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer
Camilla Wendt et al.
ACTA ONCOLOGICA (2019)
Two truncating variants in FANCC and breast cancer risk
Thilo Dork et al.
SCIENTIFIC REPORTS (2019)
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
Zi-Ming Zhao et al.
BMC CANCER (2019)
Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis
Delal Akdeniz et al.
BREAST (2019)
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants
Stephanie Schubert et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
Elodie Girard et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The role of SLX4 and its associated nucleases in DNA interstrand crosslink repair
Wouter S. Hoogenboom et al.
NUCLEIC ACIDS RESEARCH (2019)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Gisella Figlioli et al.
NPJ BREAST CANCER (2019)
Individuals with &ITFANCM&IT biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility
Irene Catucci et al.
GENETICS IN MEDICINE (2018)
Biallelic truncating &ITFANCM&IT mutations cause early-onset cancer but not Fanconi anemia
Massimo Bogliolo et al.
GENETICS IN MEDICINE (2018)
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity
Harald Surowy et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
N. J. Birkbak et al.
ANNALS OF ONCOLOGY (2018)
Genetic determinants of sporadic breast cancer in Sri Lankan women
Nirmala Dushyanthi Sirisena et al.
BMC CANCER (2018)
FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
Tu Nguyen-Dumont et al.
BMC MEDICAL GENETICS (2018)
Fanconi anemia with sun-sensitivity caused by a Xeroderma pigmentosum-associated missense mutation in XPF
Isabell Popp et al.
BMC MEDICAL GENETICS (2018)
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer
Florentia Fostira et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The evolving role of DNA inter-strand crosslinks in chemotherapy
Halley B. Rycenga et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Mutational analysis of RAD51C and RAD51D genes in hereditary breast and ovarian cancer families from Murcia (southeastern Spain)
Ana Isabel Sanchez-Bermudez et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2018)
Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers A meta-analysis
Xianling Zeng et al.
MEDICINE (2018)
Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA
Maria B. Federico et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2018)
Resveratrol decreases Rad51 expression and sensitizes cisplatin-resistant MCF-7 breast cancer cells
I. Leon-Galicia et al.
ONCOLOGY REPORTS (2018)
Correlation of FANCM expression with clinical factors in luminal B breast cancer
Yiran Wang et al.
BREAST CANCER (2018)
Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
Kyaw Ze Ya Maung et al.
BLOOD CANCER JOURNAL (2018)
Somatic mutations in early onset luminal breast cancer
Giselly Encinas et al.
Oncotarget (2018)
FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange
Anaid Benitez et al.
MOLECULAR CELL (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K. Litton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
Yukihide Momozawa et al.
NATURE COMMUNICATIONS (2018)
Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
Haixia Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
Sandra Bonache et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Therapeutic targeting and patient selection for cancers with homologous recombination defects
Francien Talens et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
BRIP1/FANCJ Mutation Analysis in a Family with History of Male and Female Breast Cancer in India
Ananthapur Venkateshwari et al.
JOURNAL OF BREAST CANCER (2017)
Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database
Chang Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia
Kerstin Knies et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher et al.
LANCET ONCOLOGY (2017)
Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway
Sylvie van Twest et al.
MOLECULAR CELL (2017)
A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population
Sakineh Abbasi et al.
MOLECULAR MEDICINE REPORTS (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Compromised BRCA1-PALB2 interaction is associated with breast cancer risk
T. K. Foo et al.
ONCOGENE (2017)
Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex
Ronald S. Cheung et al.
CELL REPORTS (2017)
The FA Core Complex Contains a Homo-dimeric Catalytic Module for the Symmetric Mono-ubiquitination of FANCI-FANCD2
Paolo Swuec et al.
CELL REPORTS (2017)
RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells
Harry O. King et al.
STEM CELL REPORTS (2017)
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility
Tuomo Mantere et al.
SCIENTIFIC REPORTS (2017)
Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers
Javier Perez-Pena et al.
SCIENTIFIC REPORTS (2017)
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
Johanna I. Kiiski et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Assessing the Spectrum of Germline Variation in Fanconi Anemia Genes Among Patients With Head and Neck Carcinoma Before Age 50
Settara C. Chandrasekharappa et al.
CANCER (2017)
BRCA population screening for predicting breast cancer: for or against?
Giuseppe Lippi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Next-generation sequencing in familial breast cancer patients from Lebanon
Nadine Jalkh et al.
BMC MEDICAL GENOMICS (2017)
Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer
Hiroshi Nakagomi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer
Jia-Jia Ding et al.
REPRODUCTIVE SCIENCES (2016)
Fanconi Anemia Proteins Function in Mitophagy and Immunity
Rhea Sumpter et al.
CELL (2016)
Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients
F. Lhota et al.
CLINICAL GENETICS (2016)
Frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk
K. Pfeifer et al.
CLINICAL GENETICS (2016)
Defects in homologous recombination repair behind the human diseases: FA and HBOC
Yoko Katsuki et al.
ENDOCRINE-RELATED CANCER (2016)
BRCA2 functions: from DNA repair to replication fork stabilization
Amelie Fradet-Turcotte et al.
ENDOCRINE-RELATED CANCER (2016)
The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer
Clara Esteban-Jurado et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
The role of USP1 autocleavage in DNA interstrand crosslink repair
Mira Kim et al.
FEBS LETTERS (2016)
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
Zora Baretta et al.
MEDICINE (2016)
FANCJ at the FORK
Sharon B. Cantor et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2016)
G-quadruplex recognition and remodeling by the FANCJ helicase
Colin G. Wu et al.
NUCLEIC ACIDS RESEARCH (2016)
The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers
Yael Laitman et al.
CANCER GENETICS (2016)
BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis
Yaning Zhu et al.
ONCOTARGET (2016)
Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
Nicoletta Biglia et al.
ECANCERMEDICALSCIENCE (2016)
Mutation analysis of PALB2 gene in French breast cancer families
Francesca Damiola et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
Marissa S. Ellingson et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients
Anna P. Sokolenko et al.
CANCER LETTERS (2015)
Beyond BRCA: New hereditary breast cancer susceptibility genes
P. Economopoulou et al.
CANCER TREATMENT REVIEWS (2015)
SnapShot: Fanconi Anemia and Associated Proteins
Anderson T. Wang et al.
CELL (2015)
Genetic testing for RAD51C mutations: in the clinic and community
V. Sopik et al.
CLINICAL GENETICS (2015)
Physical interaction between SLX4 (FANCP) and XPF (FANCQ) proteins and biological consequences of interaction-defective missense mutations
Keiji Hashimoto et al.
DNA REPAIR (2015)
REV7/MAD2L2: the multitasking maestro emerges as a barrier to recombination
Julian E. Sale
EMBO JOURNAL (2015)
FANCA safeguards interphase and mitosis during hematopoiesis in vivo
Zahi Abdul-Sater et al.
EXPERIMENTAL HEMATOLOGY (2015)
The ERCC1 and ERCC4 (XPF) genes and gene products
Mandira Manandhar et al.
GENE (2015)
FANCB is essential in the male germline and regulates H3K9 methylation on the sex chromosomes during meiosis
Yasuko Kato et al.
HUMAN MOLECULAR GENETICS (2015)
REV7 counteracts DNA double-strand break resection and affects PARP inhibition
Guotai Xu et al.
NATURE (2015)
Germline RECQL mutations are associated with breast cancer susceptibility
Cezary Cybulski et al.
NATURE GENETICS (2015)
Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women
Magdalena M. Michalska et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia
Kimberly A. Rickman et al.
CELL REPORTS (2015)
FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2
Maria Castella et al.
PLoS Genetics (2015)
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
Liisa M. Pelttari et al.
SPRINGERPLUS (2015)
Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer
T. Mantere et al.
CLINICAL GENETICS (2015)
K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks
B. Zhu et al.
ONCOGENE (2015)
Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype
Sarah L. Sawyer et al.
CANCER DISCOVERY (2015)
PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China
Yong Tao Li et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2015)
A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing
Ponnumony John Solomon et al.
ITALIAN JOURNAL OF PEDIATRICS (2015)
Correlation between Selected XRCC2, XRCC3 and RAD51 Gene Polymorphisms and Primary Breast Cancer in Women in Pakistan
Z. Qureshi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
L. Zhao et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
Kaoru Niimi et al.
CANCER SCIENCE (2014)
RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis
Dan Cheng et al.
DIAGNOSTIC PATHOLOGY (2014)
Mechanism and regulation of incisions during DNA interstrand cross-link repair
Jieqiong Zhang et al.
DNA REPAIR (2014)
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Signalling dynamics in the spindle checkpoint response
Nitobe London et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Regulation of FANCD2 and FANCI monoubiquitination by their interaction and by DNA
Simonne Longerich et al.
NUCLEIC ACIDS RESEARCH (2014)
Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair
J-Y Park et al.
ONCOGENE (2014)
Relationship between Rad51 G135C and G172T Variants and the Susceptibility to Cancer: A Meta-Analysis Involving 54 Case-Control Studies
Mengmeng Zhao et al.
PLOS ONE (2014)
Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer
Sandra Kohlhase et al.
PLOS ONE (2014)
Impact of XRCC2 Arg188His Polymorphism on Cancer Susceptibility: A Meta-Analysis
Yazhou He et al.
PLOS ONE (2014)
Modularized Functions of the Fanconi Anemia Core Complex
Yaling Huang et al.
CELL REPORTS (2014)
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer
R. Fagerholm et al.
ANNALS OF ONCOLOGY (2013)
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4
Yonghwan Kim et al.
BLOOD (2013)
Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families
Gorka Ruiz de Garibay et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Analysis of the Novel Fanconi Anemia Gene SLX4/FANCP in Familial Breast Cancer Cases
Janine L. Bakker et al.
HUMAN MUTATION (2013)
Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles
Ana Osorio et al.
HUMAN MUTATION (2013)
Silencing of Fanconi Anemia Complementation Group F Exhibits Potent Chennosensitization of Mitomycin C Activity in Breast Cancer Cells
Jiankun Yu et al.
JOURNAL OF BREAST CANCER (2013)
Fanconi anemia signaling network regulates the spindle assembly checkpoint
Grzegorz Nalepa et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population
Nadhir Litim et al.
MOLECULAR ONCOLOGY (2013)
The roles of DNA polymerase ζ and the Y family DNA polymerases in promoting or preventing genome instability
Shilpy Sharma et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2013)
Hereditary Breast/Ovarian Cancer Syndrome A Primer for Obstetricians/Gynecologists
Dana Meaney-Delman et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2013)
DNARepair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes
Libero Santarpia et al.
ONCOLOGIST (2013)
Assessment of SLX4 Mutations in Hereditary Breast Cancers
Sohela Shah et al.
PLOS ONE (2013)
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
Ana Blanco et al.
PLOS ONE (2013)
Architecture and DNA Recognition Elements of the Fanconi Anemia FANCM-FAAP24 Complex
Rachel Coulthard et al.
STRUCTURE (2013)
Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer
Susan M. Domchek et al.
CANCER DISCOVERY (2013)
Rare Mutations in XRCC2 Increase the Risk of Breast Cancer
D. J. Park et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
Juana Fernandez-Rodriguez et al.
BMC CANCER (2012)
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
Katharina Schlacher et al.
CANCER CELL (2012)
A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar et al.
CLINICAL CANCER RESEARCH (2012)
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Hyungjin Kim et al.
GENES & DEVELOPMENT (2012)
Analysis of RAD51C Germline Mutations in High-Risk Breast and Ovarian Cancer Families and Ovarian Cancer Patients
Ella R. Thompson et al.
HUMAN MUTATION (2012)
Fanconi Anemia Complementation Group A (FANCA) Protein Has Intrinsic Affinity for Nucleic Acids with Preference for Single-stranded Forms
Fenghua Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Distinct Roles of FANCO/RAD51C Protein in DNA Damage Signaling and Repair IMPLICATIONS FOR FANCONI ANEMIA AND BREAST CANCER SUSCEPTIBILITY
Kumar Somyajit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
Irene Catucci et al.
PLOS ONE (2012)
Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells
Yanlin Li et al.
PLOS ONE (2012)
The structure of the FANCM-MHF complex reveals physical features for functional assembly
Yuyong Tao et al.
NATURE COMMUNICATIONS (2012)
Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles
Ella R. Thompson et al.
PLOS GENETICS (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
PALB2 analysis in BRCA2-like families
M. A. Adank et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer
Paolo Peterlongo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival
Verena Varadi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Relative contributions of BRCA1 and BRCA2 mutations to triple-negative breast cancer in Ashkenazi Women
E. Comen et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer
Rosa Landwehr et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family
Szilvia Solyom et al.
CANCER LETTERS (2011)
PALB2 mutations in familial breast and pancreatic cancer
Erin W. Hofstatter et al.
FAMILIAL CANCER (2011)
Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1
Sharon B. Cantor et al.
FUTURE ONCOLOGY (2011)
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
Shiyu Zhang et al.
GYNECOLOGIC ONCOLOGY (2011)
Mutations in Fanconi anemia genes and the risk of esophageal cancer
Mohammad R. Akbari et al.
HUMAN GENETICS (2011)
RING Finger and WD Repeat Domain 3 (RFWD3) Associates with Replication Protein A (RPA) and Facilitates RPA-mediated DNA Damage Response
Shangfeng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Germline PALB2 mutation analysis in breast-pancreas cancer families
Zsofia K. Stadler et al.
JOURNAL OF MEDICAL GENETICS (2011)
Mutations of the SLX4 gene in Fanconi anemia
Yonghwan Kim et al.
NATURE GENETICS (2011)
Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway
Kimiyo N. Yamamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Single Nucleotide Polymorphisms in the Homologous Recombination Repair Genes and Breast Cancer Risk in Polish Women
Hanna Romanowicz-Makowska et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer
Eriko Tokunaga et al.
BREAST CANCER (2011)
Significance of the Fanconi Anemia FANCD2 Protein in Sporadic and Metastatic Human Breast Cancer
Philip S. Rudland et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The Fanconi Anemia Protein, FANCG, Binds to the ERCC1-XPF Endonuclease via Its Tetratricopeptide Repeats and the Central Domain of ERCC1
Chuan Wang et al.
BIOCHEMISTRY (2010)
FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses
Fan Zhang et al.
CHROMOSOMA (2010)
FANCM: fork pause, rewind and play
Spencer J. Collis et al.
EMBO JOURNAL (2010)
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
Nancie Petrucelli et al.
GENETICS IN MEDICINE (2010)
Expression of FANCD2 in Sporadic Breast Cancer and Clinicopathological Analysis
Bo Zhang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2010)
Risk of breast cancer in male BRCA2 carriers
D. G. R. Evans et al.
JOURNAL OF MEDICAL GENETICS (2010)
Down-Regulation of Rad51 Expression Overcomes Drug Resistance to Gemcitabine in Human Non-Small-Cell Lung Cancer Cells
Min-Shao Tsai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance
James B. Wilson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
MECHANISMS OF DISEASE Susceptibility Pathways in Fanconi's Anemia and Breast Cancer
Alan D. D'Andrea
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
Ashok R. Venkitaraman
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
Maria J. Garcia et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features
E. Barroso et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells
Tomomi Ueki et al.
CANCER RESEARCH (2009)
Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition
Maria J. Garcia et al.
CARCINOGENESIS (2009)
Human SLX4 Is a Holliday Junction Resolvase Subunit that Binds Multiple DNA Repair/Recombination Endonucleases
Samira Fekairi et al.
CELL (2009)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
FANCI Binds Branched DNA and Is Monoubiquitinated by UBE2T-FANCL
Simonne Longerich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity
Ananya Choudhury et al.
MOLECULAR CANCER THERAPEUTICS (2009)
FANCM Connects the Genome Instability Disorders Bloom's Syndrome and Fanconi Anemia
Andrew J. Deans et al.
MOLECULAR CELL (2009)
Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction
Martin C. Mahoney et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The Fanconi anaemia/BRCA pathway and cancer susceptibility.: Searching for new therapeutic targets
M. Jose Garcia et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function
Arcangela De Nicolo et al.
CLINICAL CANCER RESEARCH (2008)
Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families
Frederic Guenard et al.
JOURNAL OF HUMAN GENETICS (2008)
Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma
Satyabrata Sinha et al.
MOLECULAR CANCER (2008)
FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway
Masamichi Ishiai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations
Christopher A. Haiman et al.
HUMAN MOLECULAR GENETICS (2008)
Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
Petra van der Groep et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers
Minjie Wei et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients
Tomo Suga et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
The spindle-assembly checkpoint in space and time
Andrea Musacchio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair
Agata Smogorzewska et al.
CELL (2007)
Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer
Honglin Song et al.
PLOS ONE (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Insights into Fanconi Anaemia from the structure of human FANCE
Ravi K. Nookala et al.
NUCLEIC ACIDS RESEARCH (2007)
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Sheila Seal et al.
NATURE GENETICS (2006)
FANCD2 associated with sporadic breast cancer risk
E. Barroso et al.
CARCINOGENESIS (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly
AM Gurtan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000
L Tryggvadottir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ
R Litman et al.
CANCER CELL (2005)
Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases
A Veronesi et al.
BMC CANCER (2005)
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer
AG Lewis et al.
BREAST CANCER RESEARCH (2005)
The Fanconi anemia gene product FANCF is a flexible adaptor protein
F Léveillé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
K Yoshida et al.
CANCER SCIENCE (2004)
DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains
XC Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice
S Houghtaling et al.
GENES & DEVELOPMENT (2003)
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals
JL Rutter et al.
HUMAN MUTATION (2003)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer
S Rafii et al.
HUMAN MOLECULAR GENETICS (2002)
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function
SB Cantor et al.
CELL (2001)
The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
JP de Winter et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
